Starch–poly(ε‐caprolactone) and starch–poly(lactic acid) fibre‐mesh scaffolds for bone tissue engineering applications: structure, mechanical properties and degradation behaviour

In scaffold‐based tissue engineering strategies, the successful regeneration of tissues from matrix‐producing connective tissue cells or anchorage‐dependent cells (e.g. osteoblasts) relies on the use of a suitable scaffold. This study describes the development and characterization of SPCL (starch with ε‐polycaprolactone, 30:70%) and SPLA [starch with poly(lactic acid), 30:70%] fibre‐meshes, aimed at application in bone tissue‐engineering strategies. Scaffolds based on SPCL and SPLA were prepared from fibres obtained by melt‐spinning by a fibre‐bonding process. The porosity of the scaffolds was characterized by microcomputerized tomography (µCT) and scanning electron microscopy (SEM). Scaffold degradation behaviour was assessed in solutions containing hydrolytic enzymes (α‐amylase and lipase) in physiological concentrations, in order to simulate in vivo conditions. Mechanical properties were also evaluated in compression tests. The results show that these scaffolds exhibit adequate porosity and mechanical properties to support cell adhesion and proliferation and also tissue ingrowth upon implantation of the construct. The results of the degradation studies showed that these starch‐based scaffolds are susceptible to enzymatic degradation, as detected by increased weight loss (within 2 weeks, weight loss in the SPCL samples reached 20%). With increasing degradation time, the diameter of the SPCL and SPLA fibres decreases significantly, increasing the porosity and consequently the available space for cells and tissue ingrowth during implantation time. These results, in combination with previous cell culture studies showing the ability of these scaffolds to induce cell adhesion and proliferation, clearly demonstrate the potential of these scaffolds to be used in tissue engineering strategies to regenerate bone tissue defects. Copyright © 2008 John Wiley & Sons, Ltd.

[1]  R. Langer,et al.  Selected advances in drug delivery and tissue engineering. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[2]  G. Vunjak‐Novakovic,et al.  Culture of organized cell communities. , 1998, Advanced drug delivery reviews.

[3]  M. B. Claase,et al.  Evaluation of two biodegradable polymeric systems as substrates for bone tissue engineering. , 2003, Tissue engineering.

[4]  H. S. Azevedo,et al.  Understanding the enzymatic degradation of biodegradable polymers and strategies to control their degradation rate , 2005 .

[5]  A. Kundu,et al.  Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. , 2006, Journal of biomedical materials research. Part A.

[6]  Dietmar Werner Hutmacher,et al.  State of the art and future directions of scaffold‐based bone engineering from a biomaterials perspective , 2007, Journal of tissue engineering and regenerative medicine.

[7]  Hideto Tsuji,et al.  Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and applications. , 2005, Macromolecular bioscience.

[8]  V. Maquet,et al.  Design of Macroporous Biodegradable Polymer Scaffolds for Cell Transplantation , 1997 .

[9]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[10]  A. Güner,et al.  Degradation of PLA, PLGA homo‐ and copolymers in the presence of serum albumin: a spectroscopic investigation , 2000 .

[11]  Antonios G Mikos,et al.  Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. , 2006, Tissue engineering.

[12]  R. L. Reis,et al.  A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes , 2007, Journal of materials science. Materials in medicine.

[13]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[14]  Gordana Vunjak-Novakovic,et al.  Bioreactors mediate the effectiveness of tissue engineering scaffolds , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Lijian Liu,et al.  Selective Enzymatic Degradations of Poly(l-lactide) and Poly(ε-caprolactone) Blend Films , 2000 .

[16]  H. Tsuji,et al.  Enzymatic Degradation of Biodegradable Polyester Composites of Poly(L-lactic acid) and Poly(ε-caprolactone) , 2006 .

[17]  T. Park,et al.  A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. , 2000, Journal of biomedical materials research.

[18]  M. Amiji,et al.  Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. , 2002, International journal of pharmaceutics.

[19]  C. Vacanti,et al.  An overview of tissue engineered bone. , 1999, Clinical orthopaedics and related research.

[20]  Antonios G Mikos,et al.  In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. , 2006, Tissue engineering.

[21]  Antonios G. Mikos,et al.  CHAPTER 21 – POLYMER SCAFFOLD PROCESSING , 2000 .

[22]  Rui L Reis,et al.  Response of micro- and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering. , 2007, Biomaterials.

[23]  Suming Li,et al.  Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. , 1999 .

[24]  A. Mikos,et al.  The Importance of New Processing Techniques in Tissue Engineering , 1996, MRS bulletin.

[25]  Manuela E. Gomes,et al.  8 – Tissue engineering using natural polymers , 2007 .

[26]  Francisco M Gama,et al.  In vitro assessment of the enzymatic degradation of several starch based biomaterials. , 2003, Biomacromolecules.

[27]  W. Young,et al.  Tissue engineering for bone regeneration using differentiated alveolar bone cells in collagen scaffolds. , 2003, Tissue engineering.

[28]  P. Ma,et al.  Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. , 1999, Journal of biomedical materials research.

[29]  W. D. de Jong,et al.  Tissue response to partially in vitro predegraded poly-L-lactide implants. , 2005, Biomaterials.

[30]  J C Middleton,et al.  Synthetic biodegradable polymers as orthopedic devices. , 2000, Biomaterials.

[31]  Antonios G Mikos,et al.  Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. , 2003, Journal of biomedical materials research. Part A.

[32]  X. Jing,et al.  Enzymatic degradation of poly(ε-caprolactone) film in phosphate buffer solution containing lipases , 1997 .

[33]  N. Tietz,et al.  Lipase in serum--the elusive enzyme: an overview. , 1993, Clinical chemistry.

[34]  A. Atala.  Engineering tissues, organs and cells , 2007, Journal of tissue engineering and regenerative medicine.

[35]  J M Powers,et al.  Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. , 1995, Journal of biomaterials science. Polymer edition.

[36]  W. Junge,et al.  Evaluation of a new assay for pancreatic amylase: performance characteristics and estimation of reference intervals. , 1989, Clinical biochemistry.

[37]  Antonios G. Mikos,et al.  Biodegradable polymer scaffolds to regenerate organs , 1995 .

[38]  X. Jing,et al.  Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solution , 1999 .

[39]  Colleen L Flanagan,et al.  Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. , 2005, Biomaterials.

[40]  M. Vallet‐Regí,et al.  Long term degradation of poly(ɛ-caprolactone) films in biologically related fluids , 2006 .

[41]  R. Zhuo,et al.  Enzyme-catalyzed polymerization and degradation of copolymers prepared from ϵ-caprolactone and poly(ethylene glycol) , 2003 .

[42]  M S Chapekar,et al.  Tissue engineering: challenges and opportunities. , 2000, Journal of biomedical materials research.

[43]  D J Mooney,et al.  Development of biocompatible synthetic extracellular matrices for tissue engineering. , 1998, Trends in biotechnology.